Bedside tests of muscle mass in older adults with Type 2 diabetes

Kenneth M. Madden; Boris Feldman; Shane Arishenkoff; Graydon S. Meneilly; Kenneth M. Madden; Boris Feldman; Shane Arishenkoff; Graydon S. Meneilly

doi:10.3934/medsci.2022022

AIMS Medical Science

2022, Volume 9, Issue 3: 433-446. doi: 10.3934/medsci.2022022

Previous Article Next Article

Research article

Bedside tests of muscle mass in older adults with Type 2 diabetes

Running title: Bedside measures of muscularity

1.
Gerontology and Diabetes Research Laboratory, Division of Geriatric Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
2.
Centre for Hip Health and Mobility, University of British Columbia, Vancouver, British Columbia, Canada
3.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Received: 07 June 2022 Revised: 27 July 2022 Accepted: 04 August 2022 Published: 24 August 2022

Objective
Diabetes and sarcopenia often coexist in older adults, suggesting a possible bidirectional association. Available bedside measures of muscle mass consist of bedside ultrasound (MT, quadriceps muscle thickness) and Bioelectrical Impedance Analysis (BIA). We examined the association between ultrasound measures and BIA measures of muscle in older adults with measures of strength, performance and frailty in older adults with diabetes.
Design
Cross-sectional study.
Methods
81 subjects (age ≥ 65; mean age 80.8 ± 0.6 years, 27 women, 53 men) were recruited sequentially from geriatric medicine clinics. Each subject had Lean Body Mass (LBM, by BIA, in kg), grip strength, gait speed, Cardiovascular Health Study index (frailty) and MT (in cm) measured. All initial models were adjusted for biological sex.
Results
In our final parsimonious models, only MT (as opposed to LBM) showed a significant correlation with grip strength (Standardized β = 0.217 ± 0.078; p = 0.007) and frailty (Standardized β = 0.276 ± 0.109; p = 0.013). Neither MT or LBM showed a significant association with subject performance (gait speed).
Conclusions
Unlike BIA, bedside ultrasound measures of muscle thickness showed strong associations with both grip strength and frailty in the older adult population with diabetes, suggesting that bedside measures of MT might be a more clinically useful modality to assess muscularity in this patient population. Neither BIA or MT measures of subject muscularity showed any association with our performance indicator (gait speed).
- sarcopenia,
- bedside ultrasound,
- bioelectrical impedance analysis,
- diabetes,
- geriatric medicine,
- frailty
Citation: Kenneth M. Madden, Boris Feldman, Shane Arishenkoff, Graydon S. Meneilly. Bedside tests of muscle mass in older adults with Type 2 diabetes[J]. AIMS Medical Science, 2022, 9(3): 433-446. doi: 10.3934/medsci.2022022

Related Papers:

Abstract

Objective

Diabetes and sarcopenia often coexist in older adults, suggesting a possible bidirectional association. Available bedside measures of muscle mass consist of bedside ultrasound (MT, quadriceps muscle thickness) and Bioelectrical Impedance Analysis (BIA). We examined the association between ultrasound measures and BIA measures of muscle in older adults with measures of strength, performance and frailty in older adults with diabetes.

Design

Cross-sectional study.

Methods

81 subjects (age ≥ 65; mean age 80.8 ± 0.6 years, 27 women, 53 men) were recruited sequentially from geriatric medicine clinics. Each subject had Lean Body Mass (LBM, by BIA, in kg), grip strength, gait speed, Cardiovascular Health Study index (frailty) and MT (in cm) measured. All initial models were adjusted for biological sex.

Results

In our final parsimonious models, only MT (as opposed to LBM) showed a significant correlation with grip strength (Standardized β = 0.217 ± 0.078; p = 0.007) and frailty (Standardized β = 0.276 ± 0.109; p = 0.013). Neither MT or LBM showed a significant association with subject performance (gait speed).

Conclusions

Unlike BIA, bedside ultrasound measures of muscle thickness showed strong associations with both grip strength and frailty in the older adult population with diabetes, suggesting that bedside measures of MT might be a more clinically useful modality to assess muscularity in this patient population. Neither BIA or MT measures of subject muscularity showed any association with our performance indicator (gait speed).

Abbreviations

DXA

Dual-energy X-ray absorptiometry

LBM

Lean body mass

BIA

Bioelectrical impedance analysis

CHS Index

Cardiovascular health study Index

Quadriceps muscle tissue thickness

AIC

Akaike's Information Criterion

Hg_A1c

Glycated hemoglobin

BMI

Body mass index

Acknowledgments

This work was supported by the Allan M. McGavin Foundation, who had no involvement in the study or in the preparation of the manuscript.

Conflict of interest

All authors declare no conflicts of interest in this paper. The sponsor (the Allan M. McGavin Foundation) had no role in the study design, analysis or writing of the paper.

Authors' contributions

Kenneth Madden designed the study, gathered the raw data, performed the data analysis, wrote the manuscript, and edited the manuscript; Boris Feldman gathered the raw data and edited the manuscript; Shane Arishenkoff participated in study design, reviewed the ultrasound images and edited the manuscript; Graydon S. Meneilly participated in study design and editing the manuscript.

References

[1]	Dent E, Morley JE, Cruz-Jentoft AJ, et al. (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22: 1148-1161. https://doi.org/10.1007/s12603-018-1139-9
[2]	Cruz-Jentoft AJ, Bahat G, Bauer J, et al. (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48: 16-31. https://doi.org/10.1093/ageing/afy169
[3]	Cederholm T, Cruz-Jentoft AJ, Maggi S (2013) Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 49: 111-117.
[4]	Janssen I, Shepard DS, Katzmarzyk PT, et al. (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80-85. https://doi.org/10.1111/j.1532-5415.2004.52014.x
[5]	Manini TM, Clark BC (2012) Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci 67: 28-40. https://doi.org/10.1093/gerona/glr010
[6]	Fielding RA, Vellas B, Evans WJ, et al. (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12: 249-256. https://doi.org/10.1016/j.jamda.2011.01.003
[7]	Cesari M, Landi F, Vellas B, et al. (2014) Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci 6: 192. https://doi.org/10.3389/fnagi.2014.00192
[8]	Ryerson B, Tierney EF, Thompson TJ, et al. (2003) Excess physical limitations among adults with diabetes in the US population, 1997–1999. Diabetes Care 26: 206-210. https://doi.org/10.2337/diacare.26.1.206
[9]	Kim TN, Park MS, Yang SJ, et al. (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33: 1497-1499. https://doi.org/10.2337/dc09-2310
[10]	Leenders M, Verdijk LB, van der Hoeven L, et al. (2013) Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 14: 585-592. https://doi.org/10.1016/j.jamda.2013.02.006
[11]	Guglielmi G, Ponti F, Agostini M, et al. (2016) The role of DXA in sarcopenia. Aging Clin Exp Res 28: 1047-1060. https://doi.org/10.1007/s40520-016-0589-3
[12]	Derstine BA, Holcombe SA, Goulson RL, et al. (2017) Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population. J Nutr Health Aging 21: 180-185. https://doi.org/10.1007/s12603-017-0983-3
[13]	Madden KM, Feldman B, Arishenkoff S, et al. (2021) A rapid point-of-care ultrasound marker for muscle mass and muscle strength in older adults. Age Ageing 50: 505-510. https://doi.org/10.1093/ageing/afaa163
[14]	Gonzalez MC, Heymsfield SB (2017) Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?. J Cachexia Sarcopenia Muscle 8: 187-189. https://doi.org/10.1002/jcsm.12159
[15]	Kurinami N, Sugiyama S, Morita A, et al. (2018) Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 139: 122-130. https://doi.org/10.1016/j.diabres.2018.02.009
[16]	Omura-Ohata Y, Son C, Makino H, et al. (2019) Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes. Cardiovasc Diabetol 18: 137. https://doi.org/10.1186/s12933-019-0941-y
[17]	Tsui EY, Gao XJ, Zinman B (1998) Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in Type 2 diabetes mellitus. Diabet Med 15: 125-128. https://doi.org/10.1002/(SICI)1096-9136(199802)15:2<125::AID-DIA532>3.0.CO;2-N
[18]	Madden KM, Feldman B, Arishenkoff S, et al. (2021) Point-of-care ultrasound measures of muscle and frailty measures. Eur Geriatr Med 12: 161-166. https://doi.org/10.1007/s41999-020-00401-3
[19]	American Diabetes Association.2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care (2021) 44: S15-S33. https://doi.org/10.2337/dc21-S002
[20]	Perkisas S, Baudry S, Bauer J, et al. (2018) Application of ultrasound for muscle assessment in sarcopenia: towards standardized measurements. Eur Geriatr Med 9: 739-757. https://doi.org/10.1007/s41999-018-0104-9
[21]	Strasser EM, Draskovits T, Praschak M, et al. (2013) Association between ultrasound measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength in the elderly. Age 35: 2377-2388. https://doi.org/10.1007/s11357-013-9517-z
[22]	Mirón Mombiela R, Facal de Castro F, Moreno P, et al. (2017) Ultrasonic echo intensity as a new noninvasive in vivo biomarker of frailty. J Am Geriatr Soc 65: 2685-2690. https://doi.org/10.1111/jgs.15002
[23]	Fried LP, Tangen CM, Walston J, et al. (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56: M146-M157. https://doi.org/10.1093/gerona/56.3.M146
[24]	Crawley MJ (2011) Statistics: An Introduction using R. West Sussex: Wiley.
[25]	R Core TeamR: A language and environment for statistical computing (2019). Available from: https://www.r-project.org/
[26]	Craney TA, Surles JG (2002) Model-dependent variance inflation factor cutoff values. Qual Eng 14: 391-403. https://doi.org/10.1081/QEN-120001878
[27]	Park SW, Goodpaster BH, Lee JS, et al. (2009) Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32: 1993-1997. https://doi.org/10.2337/dc09-0264
[28]	Pereira S, Marliss EB, Morais JA, et al. (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57: 56-63. https://doi.org/10.2337/db07-0887
[29]	Mesinovic J, Zengin A, De Courten B, et al. (2019) Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes 12: 1057-1072. https://doi.org/10.2147/DMSO.S186600
[30]	Morley JE, Malmstrom TK, Rodriguez-Mañas L, et al. (2014) Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 15: 853-859. https://doi.org/10.1016/j.jamda.2014.10.001
[31]	van den Berg PJ, Daoudi K, Moens HJB, et al. (2017) Feasibility of photoacoustic/ultrasound imaging of synovitis in finger joints using a point-of-care system. Photoacoustics 8: 8-14. https://doi.org/10.1016/j.pacs.2017.08.002
[32]	Stawicki SP, Braslow BM, Panebianco NL, et al. (2009) Intensivist use of hand-carried ultrasonography to measure IVC collapsibility in estimating intravascular volume status: correlations with CVP. J Am Coll Surg 209: 55-61. https://doi.org/10.1016/j.jamcollsurg.2009.02.062
[33]	Lee M, Roberts JM, Chen L, et al. (2014) Estimation of spleen size with hand-carried ultrasound. J Ultrasound Med 33: 1225-1230. https://doi.org/10.7863/ultra.33.7.1225
[34]	Stringer HJ, Wilson D (2018) The role of ultrasound as a diagnostic tool for sarcopenia. J Frailty Aging 7: 258-261. https://doi.org/10.14283/jfa.2018.24
[35]	Leone AF, Schumacher SM, Krotish DE, et al. (2012) Geriatricians' interest to learn bedside portable ultrasound (GEBUS) for application in the clinical practice and in education. J Am Med Dir Assoc 13: 308.e7-308.e10. https://doi.org/10.1016/j.jamda.2011.06.002
[36]	Perez-Sousa MA, Venegas-Sanabria LC, Chavarro-Carvajal DA, et al. (2019) Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living. J Cachexia Sarcopenia Muscle 10: 1009-1015. https://doi.org/10.1002/jcsm.12444
[37]	Toots ATM, Taylor ME, Lord SR, et al. (2019) Associations between gait speed and cognitive domains in older people with cognitive impairment. J Alzheimers Dis 71: S15-S21. https://doi.org/10.3233/JAD-181173
[38]	Pinter D, Ritchie SJ, Gattringer T, et al. (2018) Predictors of gait speed and its change over three years in community-dwelling older people. Aging 10: 144-153. https://doi.org/10.18632/aging.101365
[39]	Lipsitz LA, Manor B, Habtemariam D, et al. (2018) The pace and prognosis of peripheral sensory loss in advanced age: association with gait speed and falls. BMC Geriatr 18: 274. https://doi.org/10.1186/s12877-018-0970-5
[40]	Raspovic A (2013) Gait characteristics of people with diabetes-related peripheral neuropathy, with and without a history of ulceration. Gait Posture 38: 723-728. https://doi.org/10.1016/j.gaitpost.2013.03.009
[41]	White DK, Neogi T, Nevitt MC, et al. (2013) Trajectories of gait speed predict mortality in well-functioning older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 68: 456-464. https://doi.org/10.1093/gerona/gls197
[42]	Veronese N, Stubbs B, Volpato S, et al. (2018) Association between gait speed with mortality, cardiovascular disease and cancer: a systematic review and meta-analysis of prospective cohort studies. J Am Med Dir Assoc 19: 981-988.e7. https://doi.org/10.1016/j.jamda.2018.06.007
[43]	Moisey LL, Mourtzakis M, Cotton BA, et al. (2013) Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care 17: R206. https://doi.org/10.1186/cc12901
[44]	Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, et al. (2013) Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 17: 259-262. https://doi.org/10.1007/s12603-012-0434-0
[45]	Tsekoura M, Kastrinis A, Katsoulaki M, et al. (2017) Sarcopenia and its impact on quality of life. Adv Exp Med Biol 987: 213-218. https://doi.org/10.1007/978-3-319-57379-3_19
[46]	Mithal A, Bonjour JP, Boonen S, et al. (2013) Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int 24: 1555-1566. https://doi.org/10.1007/s00198-012-2236-y
[47]	Deutz NE, Bauer JM, Barazzoni R, et al. (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33: 929-936. https://doi.org/10.1016/j.clnu.2014.04.007
[48]	Camporez JPG, Petersen MC, Abudukadier A, et al. (2016) Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc Natl Acad Sci U S A 113: 2212-2217. https://doi.org/10.1073/pnas.1525795113
[49]	Bertakis KD, Azari R, Helms LJ, et al. (2000) Gender differences in the utilization of health care services. J Fam Pract 49: 147-152.

Reader Comments

Your name:*

Email:*
© 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)